as 02-21-2025 4:00pm EST
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Upcoming Earnings Alert:
Get ready for potential market movements as TransMedics Group Inc. TMDX prepares to release earnings report on 27 Feb 2025.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | ANDOVER |
Market Cap: | 2.4B | IPO Year: | 2019 |
Target Price: | $116.10 | AVG Volume (30 days): | 1.3M |
Analyst Decision: | Buy | Number of Analysts: | 11 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 0.94 | EPS Growth: | N/A |
52 Week Low/High: | $55.00 - $177.37 | Next Earning Date: | 02-27-2025 |
Revenue: | $401,090,000 | Revenue Growth: | 109.09% |
Revenue Growth (this year): | 81.61% | Revenue Growth (next year): | 22.52% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Khayal Tamer I | TMDX | Chief Commercial Officer | Jan 7 '25 | Sell | $80.05 | 1,083 | $86,694.15 | 20,843 | |
Khayal Tamer I | TMDX | Chief Commercial Officer | Dec 2 '24 | Sell | $86.40 | 1,084 | $93,657.60 | 20,843 |
TMDX Breaking Stock News: Dive into TMDX Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
PR Newswire
4 days ago
PR Newswire
9 days ago
Argus Research
18 days ago
PR Newswire
19 days ago
Zacks
23 days ago
Argus Research
25 days ago
Zacks
a month ago
The information presented on this page, "TMDX TransMedics Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.